OBJECTIVE: To review the occurrence and magnitude of workplace productivity loss and sick leave in inflammatory arthritis (IA) patients and to identify determinants. METHODS: PubMed, EMbase, PsycINFO and CINAHL articles to July 2012 on IA and workplace productivity loss or sick leave were reviewed. Methodological quality was assessed by a criteria list developed by the authors. RESULTS: 47 original studies were identified. The occurrence of sick leave in IA patients varied from 3.7% in the past 4 days to 84% in the past 2.5 years. Total duration of sick leave ranged from 0.1 to 11 days over 1 month. Pain and functional disability were associated with sick leave and workplace productivity loss. About 17%-88% of IA patients experienced workplace productivity loss, four studies investigated determinants. Tumour necrosis factor inhibitors were associated with reduced workplace productivity loss and sick leave. CONCLUSIONS: IA impacts worker productivity, but its estimated magnitude varies. Higher levels of sick leave and workplace productivity loss were reported for increased levels of pain and decreased levels of functional ability.
OBJECTIVE: To review the occurrence and magnitude of workplace productivity loss and sick leave in inflammatory arthritis (IA) patients and to identify determinants. METHODS: PubMed, EMbase, PsycINFO and CINAHL articles to July 2012 on IA and workplace productivity loss or sick leave were reviewed. Methodological quality was assessed by a criteria list developed by the authors. RESULTS: 47 original studies were identified. The occurrence of sick leave in IApatients varied from 3.7% in the past 4 days to 84% in the past 2.5 years. Total duration of sick leave ranged from 0.1 to 11 days over 1 month. Pain and functional disability were associated with sick leave and workplace productivity loss. About 17%-88% of IApatients experienced workplace productivity loss, four studies investigated determinants. Tumour necrosis factor inhibitors were associated with reduced workplace productivity loss and sick leave. CONCLUSIONS:IA impacts worker productivity, but its estimated magnitude varies. Higher levels of sick leave and workplace productivity loss were reported for increased levels of pain and decreased levels of functional ability.
Authors: Ronald A Wasserman; Chad M Brummett; Jenna Goesling; Alex Tsodikov; Afton L Hassett Journal: Reg Anesth Pain Med Date: 2014 Jan-Feb Impact factor: 6.288
Authors: Manasi M Mittinty; James M Elliott; David J Hunter; Michael K Nicholas; Lyn M March; Murthy N Mittinty Journal: Clin Rheumatol Date: 2022-01-07 Impact factor: 2.980
Authors: Monique A M Gignac; Selahadin Ibrahim; Peter M Smith; Vicki Kristman; Dorcas E Beaton; Cameron A Mustard Journal: Ann Work Expo Health Date: 2018-04-18 Impact factor: 2.179
Authors: Sharon L Brennan-Olsen; S Cook; M T Leech; S J Bowe; P Kowal; N Naidoo; I N Ackerman; R S Page; S M Hosking; J A Pasco; M Mohebbi Journal: BMC Musculoskelet Disord Date: 2017-06-21 Impact factor: 2.362
Authors: Antje van der Zee-Neuen; Polina Putrik; Sofia Ramiro; Andras P Keszei; Ihsane Hmamouchi; Maxime Dougados; Annelies Boonen Journal: Arthritis Res Ther Date: 2017-09-29 Impact factor: 5.156